Cellectar Biosciences, Inc.
Nasdaq CLRB · Florham Park, NJ
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Cellectar Biosciences, Inc. is a clinical trial sponsor based in Florham Park, NJ, listed as Nasdaq CLRB. It has 5 active clinical trials with 479 planned participants, across 12 therapeutic areas. Since 2021 it has completed 3 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq CLRB
Fundraising
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Cellectar Biosciences, Inc
Cellectar Biosciences, Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 479 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 3 trials and stopped 0 early.
Cellectar Biosciences, Inc is based in Florham Park, NJ and is listed as Nasdaq CLRB. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Cellectar Biosciences, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.
Approve Suite is not affiliated with Cellectar Biosciences, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.